van den Brink W

3Amsterdam University Medical Centers, Department of Psychiatry, Amsterdam, The Netherlands.

9 papers · ORCID

ArticlePsychedelics

Psychedelic-assisted therapy for people with gambling disorder?

Romero P, Czakó A, van den Brink W +1

Europe PMC2024
ArticlePsilocybin

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.

Breeksema JJ, Niemeijer A, Krediet E +5

Europe PMC2024
ArticleKetamine

Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study.

Breeksema JJ, Niemeijer A, Kuin B +5

Europe PMC2023
ArticleKetamine

Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study.

Breeksema JJ, Niemeijer A, Kuin B +6

Europe PMC2022
ArticleMDMA

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.

Breeksema JJ, Kuin BW, Kamphuis J +3

Europe PMC2022
ArticlePsilocybin

The therapeutic potential of psilocybin: a systematic review.

van Amsterdam J, van den Brink W

Europe PMC2022
ArticlePsilocybin

Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.

Schimmers N, Breeksema JJ, Smith-Apeldoorn SY +3

Europe PMC2022
ArticlePsilocybin

[Psychedelics in the treatment of PTSD].

Vermetten E, Krediet E, Bostoen T +3

Europe PMC2020
ArticlePsilocybin

[Psychedelics for existential distress in terminally ill patients].

Schimmel N, Breeksema JJ, Veraart JKE +2

Europe PMC2020